AI-Enhanced MRI Tool for Multiple Sclerosis Treatment Monitoring in NHS
The clinical trial NCT07111637, sponsored by Queen Mary University of London in collaboration with icometrix, is assessing the AI software 'icobrain ms' for its effectiveness in enhancing MRI evaluations for Multiple Sclerosis (MS) treatment monitoring.